The acne treatment market focuses on products and therapies designed to manage and reduce acne, a common skin condition affecting people of all ages, especially adolescents. It includes topical creams, oral medications, antibiotics, and advanced dermatological procedures. Market growth is driven by the rising prevalence of acne, increasing awareness about skincare, and advancements in treatment technologies. Over-the-counter products and prescription treatments are both in demand, with growing interest in personalized and combination therapies. North America leads the market, while Asia-Pacific is emerging rapidly due to a large population and increasing skincare concerns.
According to Fortune Business Insights, the global acne treatment market was valued at USD 11.62 billion in 2024 and is projected to grow from USD 12.19 billion in 2025 to USD 17.48 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.3% during the forecast period. In 2023, North America led the market with a 49.14% share.
In October 2023, tbh Skincare inked a deal with Coles, one of Australia’s largest supermarket chains, to distribute its acne treatment products across 857 stores. This move enhances product accessibility and taps into the booming retail wellness sector.